FDA Adverse Event Injury Summary report: N

AMPLATZER PFO OCCLUDER

MDR report key: 12277234 · Received August 4, 2021

Report

Report Number
2135147-2021-00311
Event Type
Injury
Date Received
August 4, 2021
Date of Event
July 14, 2021
Report Date
September 14, 2021
Manufacturer
ABBOTT MEDICAL
Product Code
MLV
PMA / PMN Number
P120021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

CORRECTION: UPON REVIEW, THE AMPLATZER PFO OCCLUDER UNDER MANUFACTURING REPORT NUMBER 2135147-2021-00311 SHOULD NOT HAVE BEEN SUBMITTED AS A MEDICAL DEVICE REPORT (MDR) AS THE EVENT DID NOT INDICATE A MALFUNCTION CAUSED A SERIOUS EVENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT IN 2018, A 25MM AMPLATZER PFO OCCLUDER WAS IMPLANTED IN A SMALL ATRIAL SEPTAL DEFECT (ASD) NEAR THE PATENT FORAMEN OVALE (PFO). ON AN UNKNOWN DATE, RESIDUAL LEAK WAS OBSERVED FROM THE PFO. THEREFORE, ON (B(6) 2021, A SECOND 25MM AMPLATZER PFO OCCLUDER WAS IMPLANTED BESIDE THE FIRST OCCLUDER WITH RESOLUTION OF THE RESIDUAL LEAK. THE PATIENT WAS HEMODYNAMICALLY STABLE THROUGHOUT THE PROCEDURE AND WAS REPORTED TO BE IN STABLE CONDITION POST-OPERATIVELY.

Additional Manufacturer Narrative · 1

THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN A SUBSEQUENT SUBMISSION.

Description of Event or Problem · 1

IT WAS REPORTED THAT IN 2018, A 25MM AMPLATZER PFO OCCLUDER WAS IMPLANTED IN A SMALL ATRIAL SEPTAL DEFECT (ASD) NEAR THE PATENT FORAMEN OVALE (PFO). ON AN UNKNOWN DATE, RESIDUAL LEAK WAS OBSERVED. THEREFORE, ON (B)(6) 2021, A SECOND 25MM AMPLATZER PFO OCCLUDER WAS IMPLANTED BESIDE THE FIRST OCCLUDER WITH RESOLUTION OF THE RESIDUAL LEAK. THE PATIENT WAS HEMODYNAMICALLY STABLE THROUGHOUT THE PROCEDURE AND WAS REPORTED TO BE IN STABLE CONDITION POST-OPERATIVELY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1169859 AMPLATZER PFO OCCLUDER TRANSCATHETER SEPTAL OCCLUDER MLV ABBOTT MEDICAL 9-PFO-025

Patients

Seq Age Sex Outcome Treatment
1 35 YR Hospitalization| R